Loeb Partners Corp’s Edwards Lifesciences EW Stock Holding History

Loeb Partners Corp’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,200	Closed	-$62K	–	183
2018 Q4	$62K	Buy	+1,200	New	+$60.7K	0.03%	160

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Loeb Partners Corp's EW Position: Q1 2019 in Review

Loeb Partners Corp sold out of Edwards Lifesciences (EW) in Q1 2019, closing a stake of 1,200 shares — an estimated $62K sold.

Loeb Partners Corp first reported a position in EW in Q4 2018 and held it in 1 quarter. The position peaked at $62K in Q4 2018. 922 funds tracked by Wall St. Rank hold EW as of Q1 2019.

Loeb Partners Corp reported no remaining Edwards Lifesciences position as of Q1 2019 after selling out during the quarter.
Loeb Partners Corp sold 1,200 Edwards Lifesciences shares in Q1 2019, an estimated $62K.
Loeb Partners Corp first reported a position in Edwards Lifesciences in Q4 2018 and held it in 1 quarter.
Loeb Partners Corp's Edwards Lifesciences position peaked at $62K in Q4 2018.
922 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on Loeb Partners Corp's 13F filing for Q1 2019, filed 14 May 2019.